The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: Histopathological evaluation of a series

Surgical Neurology

Volumn 49, Issue 4, 1998, Pages 436-440

  Ginsberg, Lawrence E ^a   Fuller, Gregory N ^a   Hashmi, Masood ^a   Leeds, Norman E ^a   Schomer, Donald F ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Brain tumors; Contrast enhancement; Magnetic resonance imaging

Indexed keywords

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN BIOPSY; BRAIN TUMOR; CANCER GRADING; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; GLIOBLASTOMA; GLIOMA; HUMAN; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; PREOPERATIVE EVALUATION; TREATMENT PLANNING;

ADULT; AGED; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SUPRATENTORIAL NEOPLASMS;

EID: 0032054259     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-3019(97)00360-1     Document Type: Article

References (19)

1. 1. Daumas-Duport C, Scheithauer B, O'Fallon J, et al. Grading of astrocytomas. A simple and reproducible method. Cancer 1988;62:2152-65.
2. 2. Shaw EG, Scheithauer BW, O'Fallon JR, et al. Oligodendrogliomas: The Mayo Clinic experience. J Neurosurg 1992;76:428-34.
3. 3. Butler AR, Horii SC, Kricheff II, Shannon MB, Budzilovich GN. Computed tomography in astrocytomas. A statistical analysis of the parameters of malignancy and the positive contrast-enhanced CT scan. Radiology 1978;129:433-9.
4. 4. Dubois PJ. Brain tumors. Supratentorial hemispheric tumors: glioma. In: Rosenberg RN, Heinz ER, eds. The clinical neurosciences. Neuroradiology. New York: Churchill Livingstone, 1984:361-455.
5. 5. Osborn AG. Diagnostic neuroradiology. St. Louis: Mosby, 1994:529-78.
6. 6. Chamberlain MC, Murovic JA, Levin VA. Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas. Neurology 1988;38:1371-4.
7. 7. Atlas SW. Intraaxial brain tumors. In: Atlas SW, ed. Magnetic resonance imaging of the brain and spine. New York: Raven Press, 1991:253-326.
8. 8. Watanabe M, Tanaka R, Takeda N. Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology 1992;34:463-9.
9. 9. Graif M, Bydder GM, Steiner RE, Niendorf P, Thomas DGT, Young IR. Contrast-enhanced MR imaging of malignant brain tumors. Am J Neoradiol 1985;6:855-62.
10. 10. Castillo M. Contrast enhancement in primary tumors of the brain and spinal cord. Neuroimaging Clin North Am 1994;4:63-80.
11. 11. Masters LT, Zimmerman RD. Imaging of supratentorial brain tumors in adults. Neuroimaging Clin North Am 1993;3:649-87.
12. 12. Perez-Cruet MJ, Adelman L, Anderson M, Roth PA, Ritter AM, Saris SC. CT-guided stereotactic biopsy of nonenhancing brain lesions. Stereotact Funct Neurosurg 1993;61:105-17.
13. 13. Kondziolka D, Lunsford LD, Martinez AJ. Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg 1993;79:533-6.
14. 14. Recht LD, Lew R, Smith TW. Suspected low-grade glioma: is deferring treatment safe? Ann Neurol 1992; 31:431-6.
15. 15. Rutherfoord GS, Hewlett RH, Truter R. Contrast enhanced imaging is critical to glioma nosology and grading. Int J Neuroradiology 1995;1:28-38.
16. 16. Burger PC. Pathologic anatomy and CT correlations in the glioblastoma multiforme. Appl Neurophysiol 1983;46:180-7.
17. 17. Glantz MJ, Burger PC, Herndon JE, et al. Influence of the type of srgery on the histologic diagnosis in patients with anaplastic gliomas. Neurology 1991;41:1741-4.
18. 18. Cairncross JG, Laperriere NJ. Low-grade glioma. To treat or not to treat? Arch Neurol 1989;46:1238-9.
19. 19. Mihara F. Non-contrast-enhancing supratentorial malignant astrocytoma: MR diagnosis. 30th Annual Meeting of the American Society of Neuroradiology, St. Louis, MO, 1992.